For those living with joint pain, there’s some good news. A recent study suggests that a pill called colchicine might help ...

CALGARY, Alberta, Jan. 29, 2025 (GLOBE NEWSWIRE) -- ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANUA) ...

According to the CDC, frequent consumption of sugary drinks is linked to adverse health outcomes that include obesity, type 2 ...

Among patients with gout in the US, Black individuals and those living in the South were associated with reduced adherence to allopurinol.

A recent study by researchers from the University of California San Diego and collaborators has uncovered a new molecular ...

In addition to ZTlido, Scilex's portfolio features Elyxyb, an oral celecoxib solution for migraines, which may also find broader use for acute pain such as tension headaches. Another product ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. | Following some ...

Rheumatologists report largely adhering to American College of Rheumatology guidelines for gout management, but show notable ...

Serum uric acid, BUN, and CREA levels were analyzed to evaluate treatment efficacy and monitor the progression of hyperuricemia. 2.11 MSU-induced acute gout model The gout mice model were conducted ...

PALO ALTO, Calif. - Scilex Holding Company (NASDAQ:SCLX), a $77.5 million market cap company known for its focus on non-opioid pain management products, reported that the U.S. Food and Drug ...

XORTX’s board of directors accepted the resignation of the Former Auditor, as of January 16, 2025 and appointed the Successor Auditor as the new auditor of the Company effective January 16, 2025, and ...

Gloperba® is the first and only liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.Over 70% of gout patients have comorbid ...